Compare · ONMD vs SLGC
ONMD vs SLGC
Side-by-side comparison of OneMedNet Corp (ONMD) and SomaLogic Inc. (SLGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ONMD and SLGC operate in Biotechnology: Commercial Physical & Biological Resarch (Health Care), so they compete in similar markets.
- SLGC is the larger of the two at $1.43B, about 38.1x ONMD ($37.6M).
- ONMD has hit the wire 2 times in the past 4 weeks while SLGC has been quiet.
- SLGC has more recent analyst coverage (6 ratings vs 0 for ONMD).
- Company
- OneMedNet Corp
- SomaLogic Inc.
- Price
- $0.71+4.08%
- $2.09-5.43%
- Market cap
- $37.6M
- $1.43B
- 1M return
- -27.82%
- -
- 1Y return
- +86.35%
- -
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 2
- 0
- Recent ratings
- 0
- 6
Latest ONMD
- OneMedNet Surpasses 90 Million Patient Journeys and 270 Million Studies within its Network
- Director Kosasa Thomas bought $250,000 worth of shares (268,817 units at $0.93), increasing direct ownership by 2% to 16,930,144 units (SEC Form 4)
- SEC Form 424B3 filed by OneMedNet Corp
- SEC Form 10-Q filed by OneMedNet Corp
- Amendment: SEC Form 10-K/A filed by OneMedNet Corp
- Chief Medical Officer Yu Jeffrey was granted 219,429 shares and bought $750,000 worth of shares (903,614 units at $0.83), increasing direct ownership by 15% to 8,449,266 units (SEC Form 4)
- Director Kosasa Thomas bought $749,999 worth of shares (876,136 units at $0.86), increasing direct ownership by 6% to 16,661,327 units (SEC Form 4)
- OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records
- OneMedNet Corp filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- OneMedNet Announces Strong 2025 Financials and Advances AI-Driven iRWD™ powered by Palantir Foundry enabling Conversational Search on Real-Time Medical Data
Latest SLGC
- OncoHost Selected to Present in Oral Minisymposium at American Association of Cancer Research (AACR) Annual Meeting 2024
- SEC Form SC 13G/A filed by SomaLogic Inc. (Amendment)
- SEC Form SC 13G/A filed by SomaLogic Inc. (Amendment)
- SEC Form 15-12G filed by SomaLogic Inc.
- SEC Form EFFECT filed by SomaLogic Inc.
- SEC Form EFFECT filed by SomaLogic Inc.
- Taich Adam returned 48,425 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Ryan Jason
- Roelke Alison Marie returned 17,143 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Post Richard A returned 57,430 shares to the company, closing all direct ownership in the company (SEC Form 4)